Where was the EPS uplift?
Most of the top-down analysis of the ASX's August reporting season has focused on the surprises and changes in expectations for the S&P/ASX 200. But most of the real action, of course, could be found among stocks that don't have large enough free float market caps to make it in to this key index.
Trying to make sense of the numbers and possibly identify an opportunity or two, we've run the numbers on changes in the consensus expectations among analysts for Earnings Per Share (EPS), using Thomson Reuters data.
Starting where everyone else starts, we count 134 stocks that over the last month experienced upward revisions in EPS expectations for fiscal 2018, compared to 232 downward revisions. The weighted average revision over the last month for the largest 200 stocks (weighted by market capitalisation) was -0.2%.
BUT much of the bad news was pre-warned - the weighted average decline over the past TWO months was -2.4%!
Smaller stocks suffered larger negative revisions. Stocks ranked 200-400 were downgraded 8.25% on a simple average but there were some large outliers in that group, led by Mt Gibson Iron (MGX), with EPS expectations slashed by 533%.
For a tempered view, the median (the mid-point) of these "second" 200 stocks was a -0.41% cut to fiscal 2018 EPS expectations over the last month, compared to a median of -0.31% for the top 200.
In aggregate the smaller stocks were mediocre. If you wanted to find a strong positive surprise, smaller stocks were the only place to look. The top 20 positive changes to consensus EPS expectations over the past two months were all for stocks ranked outside the top 70 by market cap. Only two of the top 20 had market caps greater than a billion dollars.
Below are the 20 stocks that experienced the greatest increase in consensus EPS expectations over the two previous months, according to our analysis of Thomson Reuters data.
Trying to make sense of the numbers and possibly identify an opportunity or two, we've run the numbers on changes in the consensus expectations among analysts for Earnings Per Share (EPS), using Thomson Reuters data.
Starting where everyone else starts, we count 134 stocks that over the last month experienced upward revisions in EPS expectations for fiscal 2018, compared to 232 downward revisions. The weighted average revision over the last month for the largest 200 stocks (weighted by market capitalisation) was -0.2%.
BUT much of the bad news was pre-warned - the weighted average decline over the past TWO months was -2.4%!
Smaller stocks suffered larger negative revisions. Stocks ranked 200-400 were downgraded 8.25% on a simple average but there were some large outliers in that group, led by Mt Gibson Iron (MGX), with EPS expectations slashed by 533%.
For a tempered view, the median (the mid-point) of these "second" 200 stocks was a -0.41% cut to fiscal 2018 EPS expectations over the last month, compared to a median of -0.31% for the top 200.
In aggregate the smaller stocks were mediocre. If you wanted to find a strong positive surprise, smaller stocks were the only place to look. The top 20 positive changes to consensus EPS expectations over the past two months were all for stocks ranked outside the top 70 by market cap. Only two of the top 20 had market caps greater than a billion dollars.
Below are the 20 stocks that experienced the greatest increase in consensus EPS expectations over the two previous months, according to our analysis of Thomson Reuters data.
Code | Company | Market Cap ($) | EPS chg |
NEU | Neuren Pharmaceuticals Ltd | 119,207,178.30 | 605% |
ANR | Anatara Lifesciences Ltd | 64,978,405.34 | 367% |
CGS | CogState Ltd | 125,044,532.80 | 74% |
MAI | MainstreamBPO Ltd | 56,318,223.00 | 37% |
PRT | Prime Media Group Ltd | 163,016,984.84 | 33% |
NWH | NRW Holdings Ltd | 381,894,460.62 | 32% |
ADH | Adairs Ltd | 242,177,186.10 | 29% |
BSE | Base Resources Ltd | 204,113,787.90 | 25% |
RDH | Redhill Education Ltd | 45,736,468.52 | 25% |
BAL | Bellamy's Australia Ltd | 879,465,644.97 | 22% |
ZNT | Zenitas Healthcare Ltd | 56,026,056.62 | 20% |
DOW | Downer EDI Ltd | 4,133,182,458.40 | 20% |
MOY | Millennium Minerals Ltd | 136,660,487.08 | 18% |
SMX | SMS Management & Technology Ltd | 122,680,048.60 | 16% |
HUO | Huon Aquaculture Group Ltd | 437,559,407.07 | 16% |
FWD | Fleetwood Corp Ltd | 184,949,418.36 | 16% |
FID | Fiducian Group Ltd | 134,436,782.40 | 14% |
VAH | Virgin Australia Holdings Ltd | 1,607,042,669.85 | 13% |
DRM | Doray Minerals Ltd | 83,916,058.35 | 12% |
AMI | Aurelia Metals Ltd | 88,325,928.54 | 12% |
Its an interesting table but in isolation doesn't mean much (the top two stocks, NEU and ANR, are both life science stocks clearly priced on something other than fiscal 2018 earnings forecasts, with NEU's 2018 earnings featuring one-off payments not expected to be repeated the following year) . The next step is to identify which of these stocks are worth doing more work on, verifying the rationale of these upgrades, the sustainability of the earnings uplift and whether the market has priced in the changes.
Equitable Investors Pty Ltd is a Corporate Authorised Representative (No. 001256627) and Martin Pretty is an Authorised Representative (No. 001256674) of Glennon Capital Pty Ltd (AFSL No. 338567)